Selection for Cardiac Resynchronization Therapy All in a Flash?∗ by Marwick, Thomas H.
J A C C : C A R D I O V A S C U L A R I M A G I N G VO L . 7 , N O . 1 0 , 2 0 1 4
ª 2 0 1 4 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 4 . 0 4 . 0 1 8EDITORIAL COMMENTSelection for
Cardiac Resynchronization Therapy
All in a Flash?*Thomas H. Marwick, MBBS, PHD, MPHSEE PAGE 969C ardiac resynchronization therapy (CRT) is ahighly effective treatment for some patientswith heart failure. Current guidelines re-
commend the implantation of CRT devices in patients
with left ventricular (LV) dysfunction and electrical
dyssynchrony, evidenced by a left bundle branch
block (1). Unfortunately, not all patients suitable for
CRT derive symptomatic beneﬁt—an unsatisfactory
situation, because device implantation is costly and
carries a small risk.
Despite the failure of previous CRT selection stra-
tegies involving echocardiographic techniques (2),
there have been continued efforts to predict those
most likely to beneﬁt. Because device implantation
itself provides a placebo effect, responsiveness has
been deﬁned on the basis of imaging changes or sur-
vival beneﬁt. There are problems with this approach
(3). The use of imaging to identify reverse remodeling
or improvement in ejection fraction is limited by the
test–retest reliability of the reference measurement.
The statistical challenges of using echocardiography
for identifying CRT response have been previously
emphasized in iJACC (4). Moreover, the additional
problem of using reverse remodeling as an endpoint
is that a 15% change of a severely remodeled LV is
substantially different biologically from that in a
small ventricle. Unfortunately, arguing for CRT
responsiveness based on survival is also problematic.
In the absence of a control group, it is impossible to
discern whether treated patients would have sur-
vived for a shorter time frame had a device not been
implanted.*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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relationships relevant to the contents of this paper to disclose.Of the 3 aspects of synchrony that may be improved
by CRT (atrioventricular [AV] delay, interventricular
delay, and intraventricular delay), most previous at-
tempts to use mechanical synchrony as a response
marker have focused on the latter. In fact, AV syn-
chrony may be the most important, at least in terms of
the beneﬁts of optimization (5). The consequences of
left bundle branch block explain the mechanical
markers of intraventricular dyssynchrony. Transient
premature activation of the septum and delayed
activation of the lateral wall causes inefﬁcient
contraction (6). Previous efforts to predict CRT
response have been compromised by the limitations
of methods for measuring mechanical dyssynchrony.
The initial attempts for this assessment were based on
imaging tests to measure intraventricular delay. As
these delays are short, methods of high temporal
resolution were used, such as M-mode and tissue
Doppler (6). Despite success within individual cen-
ters, these technically challenging and relatively noisy
methods were not well-suited to this purpose, and a
large multicenter study showed them to be unable to
provide useful predictive information (5). In addition,
most such studies focused on single parameters.In this issue of iJACC, investigators from Spain (7)
present the ﬁndings of a study of 200 CRT recipients
who were examined for 3 previously validated
markers of intraventricular, interventricular, and AV
dyssynchrony (8). In this study, intraventricular
dyssynchrony was evidenced by septal ﬂash, deﬁned
as a rapid contraction and relaxation of the septum
occurring during the isovolumetric contraction
period. This ﬁnding is analogous to other myocardial
motion markers that reﬂect dyssynchrony, such as
apical rocking (9). Dyssynchronous interventricular
motion was identiﬁed by exaggerated right–left
interaction (abnormal passive motion of the septum).
Long AV delay was identiﬁed by the presence of fused
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981E and A waves and diastolic mitral regurgitation, and
short left AV delay by A-wave truncation. Those with
a correctable abnormality were shown to have more
reverse remodeling at 12 months and better survival
over an average of 3 years. The predictive value of
these ﬁndings was independent of other predictors
(renal function, LV size, functional class, and trans-
mural extent of scar).
These results emphasize that a number of cardiac
ﬁndings, other than just synchrony markers, appear
to inﬂuence CRT responsiveness. Clinical variables
are important; in the MADIT-CRT (Multicenter Auto-
matic Deﬁbrillator Implantation Trial With Cardiac
Resynchronization Therapy) population with mild
heart failure, prior hospitalization for heart failure,
female sex, and nonischemic etiology were important
predictors of response, independent of left bundle
branch block, QRS duration, and LV and left
atrial volumes (10). As shown in this study, imaging
of myocardial scar may be of value. The extent of
myocardial scarring can facilitate the prediction of
reverse remodeling or functional improvement, and
the localization of scar to the posterior wall is an
important predictor of CRT nonresponse (11).
In addition to the LV markers used in this study,
a neglected association of reverse remodeling is
the status of the right ventricle (12). Both RV size
(end-diastolic area index >10.0 cm2/m2) and RV dys-
function (fractional area change $35%) are important
independent predictors of failure of reverse remod-
eling. Additionally, LV function (measured as global
longitudinal strain, cutoff <7%), and left atrial size
area <26 cm2 are important determinants of response.
The site of the implanted pacemaker lead is an
important determinant of response (13)—mal-located
leads have been documented as a source, not of only
nonresponse, but also of deterioration. Targeting the
lead to the site of maximum dyssynchrony has been
known for several years to maximize the chances of
success (14). All of these considerations reinforce the
need to consider, not only dyssynchrony, but also a
variety of other imaging parameters.These new markers of cardiac synchrony as well as
the other cardiac ﬁndings associated with CRT
responsiveness are fruits of ongoing efforts to improve
patient selection for CRT. Despite these positive
ﬁndings, however, more work needs to be done before
this approach can be incorporated into patient selec-
tion. First, we need to remain mindful of the perils of
single-center studies, especially given that the short-
comings of previous synchrony markers were exposed
in the PROSPECT (Predictors of Response to CRT)
study (2), so this work needs to be repeated in a
multicenter trial. Second, markers of CRT respon-
siveness need also to be found to predict improvement
of functional capacity and quality of life, as this
(maybe even more than remodeling and survival) is
the motivation for CRT implantation in many patients.
New “responder analysis” strategies (15) will provide
information about what we and our patients really
want to know—whether they will feel better.
The underutilization of CRT is probably based
upon the fact that its expense is hard to justify when a
substantial number of patients—at least 30% (in this
study, 50%)—fail to respond. Historically, the ration-
alization of failure to more appropriately select pa-
tients for therapy has been based on the argument
that intervention showed a prognostic beneﬁt in the
studied populations, raising the specter of fatal con-
sequences of not providing therapy. The current
acceptance in the guidelines of CRT implantation into
a large number of nonresponders, in order to provide
beneﬁt to some patients, carries an opportunity cost
for provision of other services in most resource-
constrained health systems, and seems unlikely to
be a sustainable strategy. Perhaps after the additional
developments mentioned in the previous text, imag-
ing markers will enter the guidelines for CRT
implantation.
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